NCT01663727 · Interventional trial
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
Overall registry status Completed
Phase 3
Conditions Metastatic Breast Cancer
Delaware Valley sites
- Pennsylvania Oncology Hematology Associates, Inc.; PA Oncology & Hematology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory